NCT06177483

Bioavailability Evaluation of CurQ+ Curcumin Formulation

Bioavailability Evaluation of a Micellar Curcumin Formulation (curQ+) Versus 95% Curcumin Extract in Healthy Individuals

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: ESM Technologies, LLC · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

This study is intended to evaluate how significantly a proprietary curcumin formulation (curQ+®) results in greater bioavailability compared to 95% curcumin extract over a 6-hour time period following a single oral dose in healthy men \& women.

Detailed description

This study is intended to evaluate how significantly a proprietary curcumin formulation (curQ+®) results in greater bioavailability compared to 95% curcumin extract over a 6-hour time period following a single oral dose in healthy men \& women. Bioavailability will be based upon producing the greatest plasma curcumin concentration (AUC). Secondarily, this study is intended to evaluate the safety and tolerability of the curQ+® curcumin formulation.

Conditions

• Bioavailability

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	95% curcumin extract powder	95% curcumin extract powder
DIETARY_SUPPLEMENT	curQ+ curcumin formulation	curQ+ curcumin formulation

Timeline

• Start date: 2024-03-01
• Primary completion: 2024-04-05
• Completion: 2024-09-10
• First posted: 2023-12-20
• Last updated: 2024-09-19

Locations

1 site across 1 country: United States